CN
CytoNavigator™ Experimental
Home

Tumor Immunology

Dissecting the Distinct Tumor Microenvironments of HRD and HRP Ovarian Cancer: Implications for Targeted Therapies to Overcome PARPi Resistance in HRD Tumors and Refr-actoriness in HRP Tumors

2025-11-11
上一篇：Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8+ T cell infiltration 下一篇：Chemoradiotherapy-induced ACKR2+ tumor cells drive CD8+ T cell senescence and cervical cancer recurrence

Research Services

Quick Links

Contact Us

  • 021-52235399

  • tech@novelbrain.com

  • Jiangxi:6th Building, No. 18 Shangrao Avenue, Shangrao International
    Medical Tourism Pilot Zone, Jiangxi Province, China
    Shanghai:Building 22, Chiyate Center, No. 999 Jiangyue Road, Minhang
    District, Shanghai, China
    Beijing:Tower C, Ruipu Building, No. 15 Hongjunying South Road,
    Chaoyang District, Beijing, China
    Xian:Room 2504, Saigao Business Port, Weiyang District, Xi'an City,
    Shaanxi Province, China
    Guangzhou:Room 3106, Tower B, Zhonghua International Center, No. 33
    Zhongshan 3rd Road, Yuexiu District, Guangzhou City, Guangdong Province, China
    Hong Kong:16 Science Park West Avenue, Science Park, Sha Tin, Hong Kong SAR
    Nanjing:Room 17B, Tower C, Dongyu Building, No. 18 Zhenghong Street,
    Qinhuai District, Nanjing, Jiangsu Province, China
    Wuhan:Room 4, 21st Floor, Huayin Building, No. 786 Minzhu Road, Zhongnan Road
    Subdistrict, Wuchang District, Wuhan City, Hubei Province, China
    Chengdu:Room 2218, Tower A, Mengmofang Plaza, Chenghua District, Chengdu,
    Sichuan Province, China

Copyright © Novelbio 2025. All rights reserved.
沪ICP备18031107号-1 沪公网安备31011202001835号